# PLX PHARMA INC.: Form D filings

PLX PHARMA INC., a pharmaceuticals company in Houston, TX, filed 6 Form D notices with the SEC between 2009 and 2016. The latest, on March 11, 2016, reports $1.3 million sold of a $2 million offering to 27 investors.

Find out what PLX PHARMA INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20PLX%20PHARMA%20INC.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=PLX%20PHARMA%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fplx-pharma-inc-1291520)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20PLX%20PHARMA%20INC.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=PLX%20PHARMA%20INC.&page=%2Fdata%2Fform-d%2Fcompany%2Fplx-pharma-inc-1291520)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 8285 EL RIO STREET, SUITE 130, Houston, TX, 77054
- Phone: (713) 842-1249
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1291520

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Mar 11, 2016 | New notice | $2,000,000 | $1,297,000 | $703,000 | 27 | Feb 23, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1291520/000129152016000002/0001291520-16-000002-index.htm) |
| Jul 8, 2013 | New notice | $9,000,000 | $9,000,000 | $0 | 51 | May 28, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1291520/000129152013000003/0001291520-13-000003-index.htm) |
| Mar 19, 2013 | New notice | $8,273,297 | $8,273,297 | $0 | 33 | Apr 9, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1291520/000129152013000002/0001291520-13-000002-index.htm) |
| Oct 5, 2011 | New notice | $7,000,000 | $2,893,965 | $4,106,035 | 22 | Jul 31, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1291520/000129152011000001/0001291520-11-000001-index.htm) |
| Aug 9, 2010 | New notice | $6,000,000 | $2,000,020 | $3,999,980 | 21 | Jul 22, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1291520/000129152010000002/0001291520-10-000002-index.htm) |
| Jul 9, 2009 | New notice | $3,106,961 | $3,106,961 | $0 | 26 | Jan 6, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1291520/000129152009000005/0001291520-09-000005-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Upendra Marathi | Executive Officer |  |
| Kirk Calhoun | Director |  |
| Bob Casale | Director |  |
| Gary Balkema | Director |  |
| Gary Mossman | Executive Officer |  |
| Ron Zimmerman | Executive Officer |  |
| David Jorden | Executive Officer |  |
| John Hadden II | Director |  |
| Michael Valentino | Director |  |
| Natasha Giordano | Executive Officer, Director |  |

## Other pharmaceuticals companies in Texas that filed recently

- [LUCIER PHARMACEUTICALS INC](https://specstream.ai/data/form-d/company/lucier-pharmaceuticals-inc-2158290) offering · Oct 13, 2026
- [FibroBiologics, Inc.](https://specstream.ai/data/form-d/company/fibrobiologics-inc-1958777) $1.2 million · Oct 13, 2026
- [Eos SENOLYTIX, Inc.](https://specstream.ai/data/form-d/company/eos-senolytix-inc-2129803) $750,000 · Aug 27, 2026

[Every Form D from the week of Mar 7, 2016](https://specstream.ai/data/form-d/week/2016-03-07) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what PLX PHARMA INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).